-
1
-
-
0026354712
-
Phase II trial of taxol, an active drug in the treatment of metastatic breast cancer
-
Holmes FA, Walters RS, Theriault RL, et al: Phase II trial of taxol, an active drug in the treatment of metastatic breast cancer. J Natl Cancer Inst 83:1797-1805, 1991
-
(1991)
J Natl Cancer Inst
, vol.83
, pp. 1797-1805
-
-
Holmes, F.A.1
Walters, R.S.2
Theriault, R.L.3
-
2
-
-
0027436248
-
Paclitaxel and recombinant human granulocyte colony-stimulating factor as initial chemotherapy for metastatic breast cancer
-
Reichman BS, Seidman AD, Crown JPA, et al: Paclitaxel and recombinant human granulocyte colony-stimulating factor as initial chemotherapy for metastatic breast cancer. J Clin Oncol 11:1943-1951, 1993
-
(1993)
J Clin Oncol
, vol.11
, pp. 1943-1951
-
-
Reichman, B.S.1
Seidman, A.D.2
Crown, J.P.A.3
-
5
-
-
0015462030
-
Combination cancer therapy: Presidential address
-
Frei E III: Combination cancer therapy: Presidential address. Cancer Res 32:2593-2607, 1972
-
(1972)
Cancer Res
, vol.32
, pp. 2593-2607
-
-
Frei III, E.1
-
6
-
-
0009621227
-
Combination chemotherapy
-
Perry M ed, ed 2, Baltimore, Williams & Wilkins
-
Friedland M: Combination chemotherapy, in Perry M (ed): The Chemotherapy Source Book (ed 2). Baltimore, Williams & Wilkins, 1997, pp 101-107
-
(1997)
The Chemotherapy Source Book
, pp. 101-107
-
-
Friedland, M.1
-
7
-
-
0007831904
-
Response of advanced breast carcinoma to the combination of the antimetabolite methotrexate and the alkylating agent thio-TEPA
-
Greenspan E, Fieber M, Lesnick G, et al: Response of advanced breast carcinoma to the combination of the antimetabolite methotrexate and the alkylating agent thio-TEPA. J Mt Sinai Hosp 30:246-267, 1963
-
(1963)
J Mt Sinai Hosp
, vol.30
, pp. 246-267
-
-
Greenspan, E.1
Fieber, M.2
Lesnick, G.3
-
8
-
-
0017141035
-
Combination chemotherapy for metastatic breast carcinoma
-
Canellos G, Pocock S, Taylor SI, et al: Combination chemotherapy for metastatic breast carcinoma. Cancer 38:1882-1886, 1976
-
(1976)
Cancer
, vol.38
, pp. 1882-1886
-
-
Canellos, G.1
Pocock, S.2
Taylor, S.I.3
-
9
-
-
0016689884
-
Chemotherapy of advanced breast cancer: A controlled randomized trial of cyclophosphamide versus a four-drug combination
-
Rubens R, Knight R, Hayward J: Chemotherapy of advanced breast cancer: A controlled randomized trial of cyclophosphamide versus a four-drug combination. Br J Cancer 32:730-736, 1975
-
(1975)
Br J Cancer
, vol.32
, pp. 730-736
-
-
Rubens, R.1
Knight, R.2
Hayward, J.3
-
10
-
-
0019198626
-
Single-drug vs combination cytotoxic chemotherapy in advanced breast cancer: A randomized study
-
Carmo-Pereira J, Oliveira Costa F, Henreiques E: Single-drug vs combination cytotoxic chemotherapy in advanced breast cancer: A randomized study. Eur J Cancer 16:1621-1625, 1980
-
(1980)
Eur J Cancer
, vol.16
, pp. 1621-1625
-
-
Carmo-Pereira, J.1
Oliveira Costa, F.2
Henreiques, E.3
-
11
-
-
0021038747
-
Adriamycin alone or combined with vincristine in the treatment of advanced breast cancer
-
Steiner R, Stewart JF, Cantwell BJM, et al: Adriamycin alone or combined with vincristine in the treatment of advanced breast cancer. Eur J Cancer Clin Oncol 19:1553, 1983
-
(1983)
Eur J Cancer Clin Oncol
, vol.19
, pp. 1553
-
-
Steiner, R.1
Stewart, J.F.2
Cantwell, B.J.M.3
-
12
-
-
0022444593
-
Doxorubicin versus mitomycin versus doxorubicin plus mitomycin in advanced breast cancer: A randomized study
-
Andersson M, Daugaard S, von der Maase H, et al: Doxorubicin versus mitomycin versus doxorubicin plus mitomycin in advanced breast cancer: A randomized study. Cancer Treat Rep 70:1181-1186, 1986
-
(1986)
Cancer Treat Rep
, vol.70
, pp. 1181-1186
-
-
Andersson, M.1
Daugaard, S.2
von der Maase, H.3
-
13
-
-
0022897407
-
Weekly Adriamycin versus VAC in advanced breast cancer. A randomized trial
-
Gundersen S, Kvinnsland S, Klepp O, et al: Weekly Adriamycin versus VAC in advanced breast cancer. A randomized trial. Eur J Cancer Clin Oncol 22:1431-1434, 1986
-
(1986)
Eur J Cancer Clin Oncol
, vol.22
, pp. 1431-1434
-
-
Gundersen, S.1
Kvinnsland, S.2
Klepp, O.3
-
14
-
-
0023514431
-
The effect on survival of initial chemotherapy in advanced breast cancer: Polychemotherapy versus single drug
-
Ahmann D, Schaid D, Bisel H, et al: The effect on survival of initial chemotherapy in advanced breast cancer: Polychemotherapy versus single drug. J Clin Oncol 5:1928-1932, 1987
-
(1987)
J Clin Oncol
, vol.5
, pp. 1928-1932
-
-
Ahmann, D.1
Schaid, D.2
Bisel, H.3
-
15
-
-
0023763034
-
VP-16 + Adriamycin vs. Adriamycin alone in advanced adenocarcinoma of the breast, phase II, a randomized trial: A Southwest Oncology Group study
-
Vaughn C, Green S, O'Bryan R, et al: VP-16 + Adriamycin vs. Adriamycin alone in advanced adenocarcinoma of the breast, phase II, a randomized trial: A Southwest Oncology Group study. Med Pediatr Oncol 16:312-319, 1988
-
(1988)
Med Pediatr Oncol
, vol.16
, pp. 312-319
-
-
Vaughn, C.1
Green, S.2
O'Bryan, R.3
-
16
-
-
0024999743
-
Epirubicin or epirubicin and vindesine in advanced breast cancer. A phase III study
-
Nielsen D, Dombernowsky P, Skovsgaard T, et al: Epirubicin or epirubicin and vindesine in advanced breast cancer. A phase III study. Ann Oncol 1:275-280, 1990
-
(1990)
Ann Oncol
, vol.1
, pp. 275-280
-
-
Nielsen, D.1
Dombernowsky, P.2
Skovsgaard, T.3
-
17
-
-
0026062132
-
A prospective randomized trial comparing epirubicin monochemotherapy to two fluorouracil, cyclophosphamide, and epirubicin regimens differing in epirubicin dose in advanced breast cancer patients
-
Group FES
-
Group FES: A prospective randomized trial comparing epirubicin monochemotherapy to two fluorouracil, cyclophosphamide, and epirubicin regimens differing in epirubicin dose in advanced breast cancer patients. J Clin Oncol 9:305-312, 1991
-
(1991)
J Clin Oncol
, vol.9
, pp. 305-312
-
-
-
18
-
-
0031759089
-
Cytotoxic and hormonal treatment for metastatic breast cancer: A systematic review of published randomized trials involving 31,510 women
-
Fossati R, Confalonieri C, Torri V, et al: Cytotoxic and hormonal treatment for metastatic breast cancer: A systematic review of published randomized trials involving 31,510 women. J Clin Oncol 16:3439-3460, 1998
-
(1998)
J Clin Oncol
, vol.16
, pp. 3439-3460
-
-
Fossati, R.1
Confalonieri, C.2
Torri, V.3
-
19
-
-
0018567411
-
Survival of patients with metastatic breast cancer treated with either combination or sequential chemotherapy
-
Chlebowski R, Irwin L, Pugh R, et al: Survival of patients with metastatic breast cancer treated with either combination or sequential chemotherapy. Cancer Res 39:4503-4506, 1979
-
(1979)
Cancer Res
, vol.39
, pp. 4503-4506
-
-
Chlebowski, R.1
Irwin, L.2
Pugh, R.3
-
20
-
-
0017104555
-
Combination versus sequential five-drug chemotherapy in metastatic carcinoma of the breast
-
Smalley R, Murphy S, Huguley CJ, et al: Combination versus sequential five-drug chemotherapy in metastatic carcinoma of the breast. Cancer Res 36:3911-3916, 1976
-
(1976)
Cancer Res
, vol.36
, pp. 3911-3916
-
-
Smalley, R.1
Murphy, S.2
Huguley, C.J.3
-
21
-
-
0016221645
-
Evaluation of combination vs. sequential cytotoxic chemotherapy in the treatment of advanced breast cancer
-
Baker L, Vaughn C, Al-Sarraf M, et al: Evaluation of combination vs. sequential cytotoxic chemotherapy in the treatment of advanced breast cancer. Cancer 33:513-518, 1974
-
(1974)
Cancer
, vol.33
, pp. 513-518
-
-
Baker, L.1
Vaughn, C.2
Al-Sarraf, M.3
|